Irina V Balyasnikova

Title: Irina V Balyasnikova: Innovator in Cancer Research

Introduction

Irina V Balyasnikova is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of cancer research, particularly in the development of specific binding agents that target cancer cells. With a total of 5 patents to her name, her work is paving the way for innovative treatments in oncology.

Latest Patents

Balyasnikova's latest patents include groundbreaking work on IL13Rα2 binding agents. These specific binding molecules are designed to bind to an epitope of IL13Rα2, a receptor polypeptide that is preferentially found on the surface of cancer cells rather than healthy cells. Her patents detail exemplary bispecific binding molecules that combine a fragment of an IL13Rα2 binding molecule with a peptide that provides a second function, such as a signaling function of a T cell signaling protein. Additionally, her work encompasses polynucleotides encoding these specific binding molecules, vectors, host cells, and pharmaceutical compositions aimed at preventing, treating, or ameliorating symptoms associated with cancer diseases, including glioblastoma multiforme.

Career Highlights

Throughout her career, Balyasnikova has worked with esteemed institutions such as the University of Chicago and Baylor College of Medicine. Her research has focused on innovative approaches to cancer treatment, utilizing her expertise in molecular biology and immunology.

Collaborations

Some of her notable collaborators include Maciej S Lesniak and Stephen M Gottschalk, who have contributed to her research endeavors in the field of cancer therapy.

Conclusion

Irina V Balyasnikova is a trailblazer in cancer research, with her innovative patents and collaborations significantly impacting the development of targeted therapies. Her work continues to inspire advancements in the fight against cancer.